Beverly Word Data-verified

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Researcher

Last publication 2026 Last refreshed 2026-05-02

faculty

19 h-index 63 pubs 900 cited

Biography and Research Information

OverviewAI-generated summary

Beverly Word's research investigates the molecular mechanisms underlying cancer development and treatment response, with a focus on gene expression and epigenetic modifications. Her work includes studying the effects of environmental agents, such as titanium dioxide nanoparticles, on cellular processes like histone modification and DNA methylation in human cell lines. Word has also explored the anti-cancer properties of specific drugs, including vorinostat, a histone deacetylase inhibitor, in various cancer models, such as pancreatic and triple-negative breast cancer. Her research has identified specific gene expression profiles associated with certain tumor types and patient demographics, contributing to a deeper understanding of cancer biology and potential therapeutic targets. Word holds an h-index of 19 with 62 publications and 895 citations, and has collaborated with researchers at the National Center for Toxicological Research on multiple projects.

Metrics

  • h-index: 19
  • Publications: 63
  • Citations: 900

Selected Publications

  • Abstract C054: Pharmacogenomics evaluation of histone deacetylase inhibitors on the treatment of triple-negative breast cancer subtypes (2025)
  • Exposure to a Titanium Dioxide Product Alters DNA Methylation in Human Cells (2024)
    2 citations DOI OpenAlex
  • Abstract 6251: High expression level of GSK3β in basal triple negative breast cancer: Effects of the HDAC inhibitor, vorinostat (2023)
  • Effect of titanium dioxide nanoparticles on histone modifications and histone modifying enzymes expression in human cell lines (2022)
    8 citations DOI OpenAlex
  • Abstract 1631: Anti-cancer effects of vorinostat on 3D cultured pancreatic cancer cells (2022)
    1 citation DOI OpenAlex
  • Abstract 995: Alpelisib and vorinostat modulate critical genes in basal-2 triple negative breast cancer cells and inhibit cell growth and invasion (2021)

View all publications on OpenAlex →

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics